HMS Holdings Corp. Announces Second Quarter 2013 Financial and Operating Results

HMS Holdings Corp. Announces Second Quarter 2013 Financial and Operating Results

  • Q2 revenue of $125.8 million; GAAP EPS of $0.12; Adjusted EPS of $0.20
  • First half revenue of $242.4 million; GAAP EPS of $0.20; Adjusted EPS of $0.35
  • 2013 Guidance affirmed

IRVING, Texas--(BUSINESS WIRE)-- HMS Holdings Corp. (NAS: HMSY) today announced its financial and operating results for the second quarter of 2013.

Q2 2013 Financial Summary

For the quarter ended June 30, 2013, HMS reported revenue of $125.8 million, an increase of 4.8% compared to revenue of $120.1 million for the same period a year ago. Net income for the quarter was $10.4 million or $0.12 per fully diluted share compared to net income of $13.0 million or $0.15 per fully diluted share for the same period a year ago. Adjusted EPS decreased 13.0% year over year to $0.20.

For the first half of 2013, HMS reported revenue of $242.4 million, an increase of 6.6% compared to revenue of $227.4 million for the same period a year ago. Net income for the first half was $17.4 million or $0.20 per fully diluted share compared to net income of $20.0 million or $0.23 per fully diluted share for the same period a year ago. Adjusted EPS decreased 8.0% year over year to $0.35.

"Our financial results for the quarter were in line with our revised guidance, and we are affirming our full year 2013 guidance," said Bill Lucia, Chief Executive Officer of HMS.

"We are in a dynamic healthcare environment," Lucia remarked, "as Medicaid lives shift rapidly to managed care and implementation of the Affordable Care Act proves increasingly complex. For HMS, healthcare reform serves as a significant growth driver for our business because we can help our clients maneuver through the changing landscape. We are leveraging our leadership position in Medicaid and Medicare payment integrity and adapting our proven tools to meet the needs of commercial clients with multiple lines of business."

Lucia added, "As HMS adapts to the demands of the changing industry, we are reshaping our underlying cost structure both to ensure our ability to respond to market needs with agility and flexibility, and to improve margins."

Webcast and Conference Call Information

HMS will report its second quarter 2013 financial and operating results at 9:00 a.m. E T on Friday, July 26, 2013. Individuals can access the webcast at or listen to the call at (877) 303-7208. International participants can listen to the call at (224) 357-2389.

The webcast will be archived on the website at Individuals can listen to the replay at (855) 859-2056. International participants can listen to the replay at (404) 537-3406. The passcode is 75822320. The replay will be available at Noon ET on July 26 through 11:59 p.m. ET on August 2, 2013.

The HMS Form 10-Q for the quarter ended June 30, 2013 will be filed and available on our website at on or about August 9, 2013, and will contain additional information about our results of operations for the fiscal year-to-date. This press release and the interim financial statements herein will be available at for at least a 12-month period. Shareholders and interested investors are welcome to contact Investor Relations at 212-857-5100.

About HMS Holdings Corp.

HMS Holdings Corp. (NAS: HMSY) , through its subsidiaries, is the nation's leader in coordination of benefits and program integrity services for healthcare payers. HMS's clients include health and human services programs in more than 40 states; commercial programs, including commercial plans, employers, and over 150 Medicaid managed care plans; the Centers for Medicare and Medicaid Services (CMS); and Veterans Administration facilities. As a result of the company's services, clients recovered over $3.2 billion in 2012, and saved billions more through the prevention of erroneous payments.

Use of Non-GAAP Financials

This press release includes presentations of earnings before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA. Adjusted EBITDA represents EBITDA adjusted for stock-based compensation expense. EBITDA is a measure commonly used by the capital markets to value enterprises. EBITDA is a non-GAAP financial measure and is reconciled to income before income taxes, which the Company's management believes to be the most comparable generally accepted accounting principles ("GAAP") measure. Adjusted EBITDA results are calculated by adjusting GAAP income before income taxes to exclude the effects of depreciation, amortization of intangible assets, stock-based compensation expense, and net interest expense.

This press release also includes presentations of adjusted EPS. Adjusted EPS represents EPS adjusted for stock-based compensation expense and amortization of intangibles and for the related taxes for these adjustments. Adjusted EPS is a non-GAAP financial measure and is reconciled to EPS, which the Company's management believes to be the most comparable GAAP measure.

The Company uses these non-GAAP financial measures for internal management purposes, when publicly providing guidance on possible future results, and as a means to evaluate period-to-period comparisons. The Company's management believes that these non-GAAP financial measures are a common measure used by investors and analysts to evaluate its performance. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, income before income taxes in accordance with GAAP.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements give our expectations or forecasts of future events; they do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as "anticipates," "estimates," "expects," "projects," "intends," "plans," "believes," "will," "target," "seeks," "forecast" and similar expressions and references to guidance. In particular, these include statements relating to future actions, business plans, objects and prospects, and future operating or financial performance. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. We caution you therefore against relying on any of these forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to: regulatory actions, budgetary pressures and political influences that could affect the procurement practices and operations of healthcare organizations and agencies, reducing demand for our services; our ability to continue to secure contracts through the competitive bidding process and any related protests and to accurately predict the cost and time to complete such contracts; our ability to retain clients or the loss of one or more major clients; client dissatisfaction or early termination of contracts triggering significant costs or liabilities; the development by competitors of new or superior products or services; the emergence of new competitors, or the development by our clients of in-house capacity to perform the services we offer; all the risks inherent in the development, introduction, and implementation of new products and services; our ability to manage our growth and its demands on our resources and infrastructure; our ability to successfully integrate our acquisitions; our compliance with the covenants and obligations under the terms of our credit facility and our ability to generate sufficient cash to cover our interest and principal payments thereunder; variations in our results of operations; negative results of government reviews, audits or investigations to verify our compliance with contracts and applicable laws and regulations; changing conditions in the healthcare industry which could simplify the payment process and reduce the need for and price of our services; our failure to comply with laws and regulations governing health data or to protect such data from theft and misuse; and, our ability to maintain effective information systems and protect them from damage or interruption. A further description of these and other risks, uncertainties, and related matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, which is available at under the "Investor Relations" tab. Any forward-looking statements made by us in this press release speak only as of the date of this press release. Factors or events that could cause actual results to differ may emerge from time to time and it is not possible for us to predict all of them. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.


(in thousands, except per share amounts)


Three months ended June 30,Six months ended June 30,
 2013  2012  2013  2012 
Revenue$125,809 $120,069 $242,416 $227,383 
Cost of services:
Data processing9,1888,02618,28614,920
Direct project costs12,26913,20025,53926,043
Other operating costs7,6535,98614,29011,113
Amortization of acquisition related software and intangibles8,759  8,149  16,688  16,298 
Total cost of services88,68279,598




Selling, general & administrative expenses 16,761  14,875   32,560   29,739 
Total operating expenses 105,443  94,473 




Operating income20,36625,596




Interest expense(4,047)(4,158)(7,779)(8,363)
Other income, net776209799319
Interest income 17  2  18 4 
Income before income taxes17,11221,649




Income taxes 6,692  8,669  11,276  13,574 
Net income and comprehensive income$10,420 $12,980 




Basic income per common share:
Net income per share -basic$0.12 $0.15 $0.20 $0.23 
Weighted average common shares outstanding, basic 87,674  86,196  87,408  86,030 
Diluted income per share:
Net income per share- diluted$0.12 $0.15 $0.20 $0.23 
Weighted average common shares outstanding, diluted89,023  88,351  88,919  88,429 

(in thousands, except per share and per share amounts)


June 30,December 31,
2013 2012 
Current assets:
Cash and cash equivalents$131,466$135,227

Accounts receivable, net of allowance for doubtful accounts of $1,006 and $830,
and estimated allowance for appeals of $10,949 and $6,985 at June 30, 2013
and December 31, 2012, respectively

Prepaid expenses12,40514,283
Prepaid income taxes6,986-
Current portion of deferred financing costs-3,336
Other current assets390 317 
Total current assets315,033306,177
Property and equipment, net128,058129,327
Intangible assets, net106,416109,919
Deferred financing costs9,7995,867
Other assets4,481 3,988 
Total assets$925,255 $926,052 
Liabilities and Shareholders' Equity
Current liabilities:
Accounts payable, accrued expenses and other liabilities$34,917$40,867
Acquisition related contingent consideration432588
Current portion of term loan-35,000
Deferred tax liabilities2,2892,398
Estimated liability for appeals25,341 21,787 
Total current liabilities62,979 100,640 
Long-term liabilities:
Deferred rent592500
Acquisition related contingent consideration498428
Term loan-297,500
Revolving debt302,796-
Other liabilities4,5603,305
Deferred tax liabilities58,383 60,805 
Total long-term liabilities366,829 362,538 
Total liabilities429,808 463,178 
Shareholders' equity:
Preferred stock - $.01 par value; 5,000,000 shares authorized; none issued--

Common stock - $.01 par value; 125,000,000 shares authorized;
93,185,831 shares issued and 87,760,984 shares outstanding at June 30, 2013;
92,374,539 shares issued and 86,949,692 shares outstanding at December 31, 2012

Capital in excess of par value287,132271,962
Retained earnings227,399210,003
Treasury stock, at cost; 5,424,847 shares at June 30, 2013 and at December 31, 2012(20,014)(20,014)
Total shareholders' equity495,447 462,874 
Total liabilities and shareholders' equity$925,255 $926,052 

(in thousands)


Six months ended June 30,
 2013  2012 
Operating activities:
Net income$17,396$20,023

Adjustments to reconcile net income to net

cash provided by operating activities:

Depreciation and amortization30,16226,871
Stock-based compensation expense6,1227,095
Excess tax benefit from exercised stock options(4,244)(6,842)
Read Full Story
Scroll to continue with content AD
  • DJI27024.80237.440.89%
    S&P 5002995.6829.531.00%
  • NIKKEI 22522207.21408.341.87%
    Hang Seng26503.93-17.92-0.07%
  • USD (PER EUR)1.100.00100.09%
    USD (PER CHF)1.00-0.0016-0.16%
    JPY (PER USD)108.850.47200.44%
    GBP (PER USD)1.280.01571.24%
More to Explore